Literature DB >> 22940679

High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults.

Riitta-Liisa Vasunta1, Y Antero Kesäniemi, Antti S Ylitalo, Olavi H Ukkola.   

Abstract

OBJECTIVE: Nonalcoholic fatty liver and hypertension are associated with metabolic syndrome. Both conditions increase the risk for cardiovascular morbidity. The objective of this study was to analyze whether 24-h blood pressure (BP) levels and nondipping phenomenon associate with hepatic steatosis defined as liver brightness.
METHODS: Twenty-four hour ambulatory BP measurement (ABPM) and liver brightness were investigated in a population-based cohort of 890 hypertensive (n = 433) and normotensive (n = 457) individuals aged 40-60 years. ABPM was recorded using the fully automatic SpaceLabs90207 oscillometric unit.
RESULTS: Fatty liver was associated with male sex, increased alcohol consumption, high BMI, large waist (P < 0.001 for all) and increased prevalence of smoking (P < 0.03). Values of alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), triglycerides and high-sensitivity CRP (hsCRP) were higher and high-density lipoprotein cholesterol lower (P < 0.001 for all) in individuals with fatty liver. After adjustments for BMI, sex and age, fatty liver was associated with 24-h (P < 0.005), daytime (P < 0.02) and night-time (P < 0.005) SBP measurements and DBP at daytime (P < 0.03). The association with nondipping showed only a trend (P = 0.057).
CONCLUSION: Significantly higher ambulatory daytime and night-time SBP levels were seen in individuals with fatty liver. Nondipping does not seem to associate with liver fat. The coexistence of liver fat accumulation and high BP are likely to potentiate the risk for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940679     DOI: 10.1097/HJH.0b013e3283576faf

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

Review 1.  Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease.

Authors:  Gashaw Hassen; Abhishek Singh; Gizeshwork Belete; Nidhi Jain; Ivonne De la Hoz; Genesis P Camacho-Leon; Nitsuh K Dargie; Keila G Carrera; Tadesse Alemu; Sharan Jhaveri; Nebiyou Solomon
Journal:  Cureus       Date:  2022-05-30

Review 2.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 3.  Cardiovascular disorders in the context of non-alcoholic Fatty liver disease: a literature review.

Authors:  Reza Karbasi-Afshar; Amin Saburi; Hossein Khedmat
Journal:  J Tehran Heart Cent       Date:  2014-01-12

4.  Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease.

Authors:  Sheng-Jie Wu; Hai Zou; Gui-Qi Zhu; Li-Ren Wang; Qi Zhang; Ke-Qing Shi; Ji-Bo Han; Wei-Jian Huang; Martin Braddock; Yong-Ping Chen; Ming-Hua Zheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 5.  Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge.

Authors:  Justin A Steggerda; Krishnaraj Mahendraraj; Tsuyoshi Todo; Mazen Noureddin
Journal:  World J Gastroenterol       Date:  2020-07-28       Impact factor: 5.742

Review 6.  NAFLD and cardiovascular diseases: a clinical review.

Authors:  Philipp Kasper; Anna Martin; Sonja Lang; Fabian Kütting; Tobias Goeser; Münevver Demir; Hans-Michael Steffen
Journal:  Clin Res Cardiol       Date:  2020-07-21       Impact factor: 5.460

7.  Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center.

Authors:  Spyros Michopoulos; Vasiliki I Chouzouri; Efstathios D Manios; Eirini Grapsa; Zoi Antoniou; Christos A Papadimitriou; Nikolaos Zakopoulos; Athanasios-Meletios Dimopoulos
Journal:  Clin Exp Gastroenterol       Date:  2016-01-13

8.  Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents.

Authors:  Aureliusz Kolonko; Joanna Musialik; Jerzy Chudek; Magdalena Bartmańska; Natalia Słabiak-Błaż; Agata Kujawa-Szewieczek; Piotr Kuczera; Katarzyna Kwiecień-Furmańczuk; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

9.  Mean Arterial Pressure Is Related to Incident Nonalcoholic Fatty Liver Disease among the Nonobese Female with Normal Low-Density Lipoprotein Cholesterol Levels: A Large Cohort Study in China.

Authors:  Shangbo Xu; Lan Chen; Danhua Hong; Lihua Yang; Xiaozhi Li; Xin Wang
Journal:  Gastroenterol Res Pract       Date:  2020-01-17       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.